Literature DB >> 15457995

Gadobutrol, a highly concentrated MR-imaging contrast agent: its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and perfusion imaging.

Alexander Huppertz1, Martin Rohrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15457995     DOI： 10.1007/s10406-004-0048-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  18 in total

1.  Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.

Authors:  N Anzalone
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 2.  Whole-body MRI at high field: technical limits and clinical potential.

Authors:  Fritz Schick
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

Review 3.  MRA of abdominal vessels: technical advances.

Authors:  Henrik J Michaely; Olaf Dietrich; Kambiz Nael; Sabine Weckbach; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Eur Radiol       Date:  2006-05-24       Impact factor: 5.315

Review 4.  Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children.

Authors:  Lesley J Scott
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

5.  Post-marketing surveillance of gadobutrol for contrast-enhanced magnetic resonance imaging in Japan.

Authors:  Yoshito Tsushima; Kazuo Awai; Gen Shinoda; Hiroyuki Miyoshi; Masayuki Chosa; Toshiyuki Sunaya; Jan Endrikat
Journal:  Jpn J Radiol       Date:  2018-09-19       Impact factor: 2.374

6.  An In Vitro Model of Nonattached Biofilm-Like Bacterial Aggregates Based on Magnetic Levitation.

Authors:  Pavel Domnin; Anastasiya Arkhipova; Stanislav Petrov; Elena Sysolyatina; Vladislav Parfenov; Pavel Karalkin; Andrey Mukhachev; Alexey Gusarov; Mikhail Moisenovich; Yusef Khesuani; Svetlana Ermolaeva
Journal:  Appl Environ Microbiol       Date:  2020-09-01       Impact factor: 4.792

7.  Intra-individual, randomised comparison of the MRI contrast agents gadobutrol and gadoterate in imaging the distal lower limb of patients with known or suspected osteomyelitis, evaluated in an off-site blinded read.

Authors:  Werner Pennekamp; Daniela Roggenland; Steffen Hering; Stefan Lemburg; Soeren Peters; Sabrina Sterl; Carsten Schwenke; Volkmar Nicolas
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

8.  Double-dose 1.0-M gadobutrol versus standard-dose 0.5-M gadopentetate dimeglumine in revealing small hypervascular hepatocellular carcinomas.

Authors:  Young Kon Kim; Young Hwan Lee; Chong Soo Kim; Young Min Han; Seung Bae Hwang
Journal:  Eur Radiol       Date:  2007-04-03       Impact factor: 5.315

9.  Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging.

Authors:  Cristina Lois; Ilja Bezrukov; Holger Schmidt; Nina Schwenzer; Matthias K Werner; Jürgen Kupferschläger; Thomas Beyer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-14       Impact factor: 9.236

10.  Intra-individual, randomised comparison of the MRI contrast agents gadobutrol versus gadoteridol in patients with primary and secondary brain tumours, evaluated in a blinded read.

Authors:  M Koenig; G Schulte-Altedorneburg; M Piontek; A Hentsch; P Spangenberg; C Schwenke; A Harders; L Heuser
Journal:  Eur Radiol       Date:  2013-07-04       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.